000			03337nam a22004455i 4500
001			978-1-4614-8202-4
003			DE-He213
005			20140220082500.0
007			cr nn 008mamaa
008			131106s2014 xxu| s |||| 0|eng d
020			_a9781461482024 _9978-1-4614-8202-4
024	7		_a10.1007/978-1-4614-8202-4 _2doi
050		4	_aRA1-1270
072		7	_aMBN _2bicssc
072		7	_aMED078000 _2bisacsh
082	0	4	_a613 _223
082	0	4	_a614 _223
100	1		_aBrougher, Joanna T. _eauthor.
245	1	0	_aIntellectual Property and Health Technologies _h[electronic resource] : _bBalancing Innovation and the Public's Health / _cby Joanna T. Brougher.
264		1	_aNew York, NY : _bSpringer New York : _bImprint: Springer, _c2014.
300			_aXV, 214 p. 8 illus. _bonline resource.
336			_atext _btxt _2rdacontent
337			_acomputer _bc _2rdamedia
338			_aonline resource _bcr _2rdacarrier
347			_atext file _bPDF _2rda
520			_aIntellectual Property and Health Technologies Balancing Innovation and the Public's Health   Joanna T. Brougher, Esq., MPH     At first glance, ownership of intellectual property seems straightforward: the control over an invention or idea. But with the recent explosion of new scientific discoveries poised to transform public health and healthcare systems, costly and lengthy patent disputes threaten both to undermine the attempts to develop new medical technologies and to keep potentially life-saving treatments from patients who need them.   Intellectual Property and Health Technologies grounds readers in patent law and explores how scientific research and enterprise are evolving in response. Geared specifically to the medical disciplines, it differentiates among different forms of legal protection for inventors such as patents, copyrights, trademarks and trade secrets, explains their limitations, and argues for balance between competing forces of exclusivity and availability. Chapters delve into the major legal controversies concerning medical and biotechnologies (deleted "in terms of pricing, markets, and especially the tension between innovation and access"), including:   The patent-eligibility of genes The patent-eligibility of medical process patents The rights and roles of universities and inventors The balancing of access, innovation, and profit in drug development The tension between biologics, small-molecule drugs, and their generic counterparts International patent law and access to medicine in the developing world   As these issues continue to shape and define the debate, Intellectual Property and Health Technologies enables professionals and graduate students in public health, health policy, healthcare administration, and medicine to understand patent law and how it affects the development of medical technology and the delivery of medicine.
650		0	_aMedicine.
650		0	_aPublic health.
650		0	_aPublic health laws.
650	1	4	_aMedicine & Public Health.
650	2	4	_aPublic Health.
650	2	4	_aBiomedicine general.
650	2	4	_aMedical Law.
710	2		_aSpringerLink (Online service)
773	0		_tSpringer eBooks
776	0	8	_iPrinted edition: _z9781461482017
856	4	0	_uhttp://dx.doi.org/10.1007/978-1-4614-8202-4
912			_aZDB-2-SME
999			_c92127 _d92127